O

Oue Lippo Healthcare Ltd
SGX:5WA

Watchlist Manager
Oue Lippo Healthcare Ltd
SGX:5WA
Watchlist
Price: 0.027 SGD -3.57% Market Closed
Market Cap: 120m SGD
Have any thoughts about
Oue Lippo Healthcare Ltd?
Write Note

Intrinsic Value

The intrinsic value of one 5WA stock under the Base Case scenario is 0.088 SGD. Compared to the current market price of 0.027 SGD, Oue Lippo Healthcare Ltd is Undervalued by 69%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

5WA Intrinsic Value
0.088 SGD
Undervaluation 69%
Intrinsic Value
Price
O
Worst Case
Base Case
Best Case

Valuation Backtest
Oue Lippo Healthcare Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for 5WA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about 5WA?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Oue Lippo Healthcare Ltd

Provide an overview of the primary business activities
of Oue Lippo Healthcare Ltd.

What unique competitive advantages
does Oue Lippo Healthcare Ltd hold over its rivals?

What risks and challenges
does Oue Lippo Healthcare Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Oue Lippo Healthcare Ltd.

Provide P/S
for Oue Lippo Healthcare Ltd.

Provide P/E
for Oue Lippo Healthcare Ltd.

Provide P/OCF
for Oue Lippo Healthcare Ltd.

Provide P/FCFE
for Oue Lippo Healthcare Ltd.

Provide P/B
for Oue Lippo Healthcare Ltd.

Provide EV/S
for Oue Lippo Healthcare Ltd.

Provide EV/GP
for Oue Lippo Healthcare Ltd.

Provide EV/EBITDA
for Oue Lippo Healthcare Ltd.

Provide EV/EBIT
for Oue Lippo Healthcare Ltd.

Provide EV/OCF
for Oue Lippo Healthcare Ltd.

Provide EV/FCFF
for Oue Lippo Healthcare Ltd.

Provide EV/IC
for Oue Lippo Healthcare Ltd.

What are the Revenue projections
for Oue Lippo Healthcare Ltd?

How accurate were the past Revenue estimates
for Oue Lippo Healthcare Ltd?

What are the Net Income projections
for Oue Lippo Healthcare Ltd?

How accurate were the past Net Income estimates
for Oue Lippo Healthcare Ltd?

What are the EPS projections
for Oue Lippo Healthcare Ltd?

How accurate were the past EPS estimates
for Oue Lippo Healthcare Ltd?

What are the EBIT projections
for Oue Lippo Healthcare Ltd?

How accurate were the past EBIT estimates
for Oue Lippo Healthcare Ltd?

Compare the revenue forecasts
for Oue Lippo Healthcare Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Oue Lippo Healthcare Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Oue Lippo Healthcare Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Oue Lippo Healthcare Ltd compared to its peers.

Compare the P/E ratios
of Oue Lippo Healthcare Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Oue Lippo Healthcare Ltd with its peers.

Analyze the financial leverage
of Oue Lippo Healthcare Ltd compared to its main competitors.

Show all profitability ratios
for Oue Lippo Healthcare Ltd.

Provide ROE
for Oue Lippo Healthcare Ltd.

Provide ROA
for Oue Lippo Healthcare Ltd.

Provide ROIC
for Oue Lippo Healthcare Ltd.

Provide ROCE
for Oue Lippo Healthcare Ltd.

Provide Gross Margin
for Oue Lippo Healthcare Ltd.

Provide Operating Margin
for Oue Lippo Healthcare Ltd.

Provide Net Margin
for Oue Lippo Healthcare Ltd.

Provide FCF Margin
for Oue Lippo Healthcare Ltd.

Show all solvency ratios
for Oue Lippo Healthcare Ltd.

Provide D/E Ratio
for Oue Lippo Healthcare Ltd.

Provide D/A Ratio
for Oue Lippo Healthcare Ltd.

Provide Interest Coverage Ratio
for Oue Lippo Healthcare Ltd.

Provide Altman Z-Score Ratio
for Oue Lippo Healthcare Ltd.

Provide Quick Ratio
for Oue Lippo Healthcare Ltd.

Provide Current Ratio
for Oue Lippo Healthcare Ltd.

Provide Cash Ratio
for Oue Lippo Healthcare Ltd.

What is the historical Revenue growth
over the last 5 years for Oue Lippo Healthcare Ltd?

What is the historical Net Income growth
over the last 5 years for Oue Lippo Healthcare Ltd?

What is the current Free Cash Flow
of Oue Lippo Healthcare Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Oue Lippo Healthcare Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Oue Lippo Healthcare Ltd

Current Assets 119.9m
Cash & Short-Term Investments 56.7m
Receivables 26.8m
Other Current Assets 36.3m
Non-Current Assets 1.3B
Long-Term Investments 1.2B
PP&E 8m
Intangibles 30.8m
Other Non-Current Assets 3.2m
Current Liabilities 105.6m
Accounts Payable 48.4m
Other Current Liabilities 57.2m
Non-Current Liabilities 1B
Long-Term Debt 513.8m
Other Non-Current Liabilities 507.8m
Efficiency

Earnings Waterfall
Oue Lippo Healthcare Ltd

Revenue
155.5m SGD
Cost of Revenue
-36.6m SGD
Gross Profit
118.9m SGD
Operating Expenses
-28.4m SGD
Operating Income
90.5m SGD
Other Expenses
-88m SGD
Net Income
2.4m SGD

Free Cash Flow Analysis
Oue Lippo Healthcare Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

5WA Profitability Score
Profitability Due Diligence

Oue Lippo Healthcare Ltd's profitability score is 66/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Exceptional 3-Years Revenue Growth
Positive Gross Profit
Positive Operating Income
66/100
Profitability
Score

Oue Lippo Healthcare Ltd's profitability score is 66/100. The higher the profitability score, the more profitable the company is.

5WA Solvency Score
Solvency Due Diligence

Oue Lippo Healthcare Ltd's solvency score is 26/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Short-Term Solvency
Average D/E
Positive Net Debt
26/100
Solvency
Score

Oue Lippo Healthcare Ltd's solvency score is 26/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

5WA Price Targets Summary
Oue Lippo Healthcare Ltd

There are no price targets for 5WA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for 5WA?

Click here to dive deeper.

Dividends

Oue Lippo Healthcare Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for 5WA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Oue Lippo Healthcare Ltd

Country

Singapore

Industry

Health Care

Market Cap

120m SGD

Dividend Yield

0%

Description

OUE Lippo Healthcare Ltd. is as an investment holding company, which engages in the provision of healthcare services and facilities. The firm owns, operates and invests in healthcare businesses Asian markets. The Company’s segments include Healthcare operations, Healthcare assets, Properties under development and Investments. The Healthcare Operations segment includes the operation of hospitals and trading of pharmaceutical supplies and drugs and has operations in China and Myanmar. The Properties under development segment includes development of medical facilities, healthcare-related assets and integrated mixed-used projects and has development properties in China and Malaysia. The Healthcare assets segment includes rental of investment properties and assets owned by the Company and has assets in Japan and China. The Investments segment has investments in real estate investment trust (REIT) and REIT manager. OUELH also holds a 50% equity interest in China Merchants Lippo Hospital Management (Shenzhen) Limited (CM Lippo).

Contact

6 Shenton Way, #10-09 Oue Downtown 2
www.ouelh.com

IPO

2014-06-08

Employees

-

Officers

CEO & Executive Director
Mr. Kum Meng Yet
Chief Operating Officer
Ms. Julie Carlene McCaughan
Chief Technology Officer
Mr. Sau Yan Yiu
Company Secretary
Mr. Tun Foo Chong

See Also

Discover More
What is the Intrinsic Value of one 5WA stock?

The intrinsic value of one 5WA stock under the Base Case scenario is 0.088 SGD.

Is 5WA stock undervalued or overvalued?

Compared to the current market price of 0.027 SGD, Oue Lippo Healthcare Ltd is Undervalued by 69%.

Back to Top